Skip to main content
. 2018 Apr 16;8(3):e019490. doi: 10.1136/bmjopen-2017-019490

Table 3.

Pooled OR (OR) and 95% (CI) of premenstrual syndrome and high intake of alcohol

Number of studies OR (95% CI) Fixed effects OR (95% CI) Random effects Ri* Q test P values
All studies 13 1.71 (1.63 to 1.78) 1.79 (1.39 to 2.32) 0.96 0.0001
Case-control studies 5 1.27 (1.10 to 1.47) 2.48 (1.30 to 4.76) 0.93 0.0001
Cross-sectional studies 7 2.02 (1.91 to 2.12) 1.76 (1.32 to 2.36) 0.95 0.0001
Direct calculations 12 1.91 (1.82 to 2.01) 1.90 (1.45 to 2.49) 0.95 0.0001
Quality score ≥3 8 1.20 (1.11 to 1.29) 1.41 (1.14 to 1.74) 0.81 0.001
Quality score <3 5 2.05 (1.95 to 2.16) 2.33 (1.60 to 3.41) 0.96 0.0001
Full adjustment 6 1.17 (1.08 to 1.26) 1.23 (1.03 to 1.48) 0.72 0.03
Incomplete adjustment 7 2.05 (1.95 to 2.16) 2.25 (1.66 to 3.05) 0.95 0.0001
Validated exposure 7 1.18 (1.09 to 1.27) 1.32 (1.06 to 1.64) 0.81 0.003
Non validated exposure 6 2.06 (1.95 to 2.17) 2.25 (1.66 to 3.06) 0.95 0.0004
Validated diagnosis 7 1.95 (1.85 to 2.06) 1.98 (1.31 to 3.00) 0.98 0.0001
Non validated diagnosis 6 1.26 (1.16 to 1.36) 1.58 (1.22 to 2.05) 0.86 0.001
High response rate 4 1.23 (1.06 to 1.42) 1.84 (1.07 to 3.17) 0.91 0.001
Low response rate 9 1.76 (1.68 to 1.84) 1.80 (1.32 to 2.47) 0.97 0.0001
Defined target population 8 1.23 (1.15 to 1.32) 1.45 (1.21 to 1.75) 0.78 0.001
Undefined target population 5 2.09 (1.98 to 2.21) 2.49 (1.36 to 4.58) 0.99 0.0001
US studies 9 1.92 (1.83 to 2.02) 1.91 (1.41 to 2.59) 0.96 0.0001
Rest of the world 4 1.19 (1.09 to 1.30) 1.58 (0.95 to 2.63) 0.96 0.001

*Proportion of total variance due to between-study variance.